Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Intuitive Surgical Stock Soars 17% After-Hours On Strong Q3 Print, Robotics Adoption Surge — Retail Sees ‘Rush Of Buyers’
Via Stocktwits
Tickers ISRG
Exposures Product Safety
Government Shutdown Intensifies Economic Risks, Threatening Fed's Policy Path
Via MarketMinute
Topics Economy Immigration Initial Public Offering
Tickers BA LMT NEM NOC ORCL SAIC
Exposures Economy Immigration Interest Rates
Contact Levi & Korsinsky by November 7, 2025 Deadline to Join Class Action Against Savara Inc. (SVRA)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Contact Levi &amp; Korsinsky by November 7, 2025 Deadline to Join Class Action Against Savara Inc. (SVRA)
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Contact Levi &amp; Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Foodture Inc. Continues Operations During Government Shutdown Through AI-Driven Strategies
Via Get News
Topics Artificial Intelligence Economy Supply Chain
Exposures Artificial Intelligence Product Safety Supply Chain
OpenAI Unveils ChatGPT Atlas: An AI-Powered Browser Redefining the Web Experience
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
Tickers AAPL GOOGL MSFT
Exposures Artificial Intelligence Economy Legal
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Via The Motley Fool
Tickers LLY NVO
Exposures Product Safety
Big Pharma Just Put Peptides Back on the Map – Which Players Are Still Under the Radar?
Via AB Newswire
Tickers ENTX LLY PTGX
Exposures Product Safety
Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares
Via The Motley Fool
Tickers IONS MSFT REAL TARS VERA WAY
Exposures Product Safety
Why Replimune Stock Was Soaring Today
Via The Motley Fool
Tickers BMY REPL
Exposures Product Safety
Why QuidelOrtho (QDEL) Stock Is Up Today
Via StockStory
Topics Economy Government World Trade
Tickers KO MSFT QDEL
Exposures Political Product Safety Supply Chain
Why Are Natera (NTRA) Shares Soaring Today
Via StockStory
Topics Intellectual Property
Tickers AAPL MSFT NTRA WFC
Exposures Intellectual Property Product Safety
Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
Via Newsfile
Tickers OSRH
Exposures Product Safety
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Via StockStory
Tickers BAC HIMS
Exposures Product Safety
Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results
Via Investor's Business Daily
Topics Government
Tickers CELC LLY RHHBY
Exposures Political Product Safety
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
Class Action Filed Against Savara Inc. (SVRA) - November 7, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Class Action Filed Against Savara Inc. (SVRA) - November 7, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Investors in Cytokinetics, Incorporated Should Contact Levi &amp; Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Summit Therapeutics Inc (NASDAQ:SMMT) Reports Wider-Than-Expected Q3 2025 Loss
Via Chartmill
Tickers SMMT
Exposures Product Safety
Corcept Therapeutics Stock Slips Premarket Despite Strong Cancer Trial Data Showing 40% Drop In Disease Progression Risk
Via Stocktwits
Tickers CORT
Exposures Product Safety
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Tickers GILD JNJ MRK MRNA PFE QQQ
Exposures Artificial Intelligence Intellectual Property Interest Rates
Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes
Via TokenRing AI
Topics Artificial Intelligence Economy
Tickers AMZN BFLY EXAI GOOGL GSK IBM
Exposures Artificial Intelligence Economy Product Safety
Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans
Via Benzinga
Tickers KZR
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.